72.11.Z - Scientific research and development activities
10.89.Z - Production of other food products, not elsewhere classified
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
71.20 - Technical testing and analysis
72.19.Z - Scientific research and development activities
74.10.Z - Specialized design activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
85.60.Z - Educational support activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 6,5 | 4,8 | 6,8 | 42 |
Gross profit (loss) | -2,4 | -4,3 | -4,2 | 3,4 |
EBITDA | -2,1 | -3,8 | -3,5 | 9,2 |
Net profit (loss) | -2,4 | -4,3 | -4,2 | 3,4 |
Cash | 4,9 | 3 | 2,2 | -27,6 |
Net income from sale | 0,1 | 0,5 | 0,6 | 22,3 |
Liabilities and provisions for liabilities | 2,1 | 1,7 | 6,3 | 259,4 |
Short time liabilities | 0,8 | 0,3 | 4,3 | 1485,2 |
Working assets | 5,3 | 3,5 | 2,4 | -32,2 |
Equity capital | 4,4 | 3 | 0,5 | -82,4 |
Operating profit (EBIT) | -2,4 | -4,3 | -3,9 | 8,3 |
Depreciation | 0,3 | 0,4 | 0,4 | -0,5 |
% | % | % | p.p. | |
Profitability of capital | -55 | -142,4 | -780,7 | -638,3 |
Equity capital to total assets | 67,2 | 63,6 | 7,9 | -55,7 |
Gross profit margin | -2369,8 | -923,3 | -729,4 | 193,9 |
EBITDA Margin | -2031,8 | -815,6 | -605,5 | 210,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2711 | 213 | 2757 | 2544 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane